In this study, we demonstrated CD1d is functionally associated with NAFLD and potentially affects lipid metabolism–associated transcriptional profiles, metabolomic profiles, and the gut microbiome. The gene discussed is CD1D; the disease is metabolic dysfunction-associated steatotic liver disease.